{
  "schema": "upg.factor.v1",
  "id": "ptce/federal/pppa-crc",
  "exam": [
    "PTCE"
  ],
  "domain": "Federal Requirements",
  "title": "Child-resistant packaging \u2014 oral Rx drugs (PPPA)",
  "claim": "Under 16 CFR 1700.14(a)(10) (Poison Prevention Packaging Act rules), oral prescription drugs for human use that must be dispensed by/upon prescription generally require special (child-resistant) packaging meeting \u00a71700.15, with listed product exemptions (e.g., sublingual nitroglycerin). In practice, pharmacies may dispense in non-CRC (easy-open) packaging when the patient or prescriber requests it and the pharmacy documents the request per house policy \u2014 confirm current CPSC/PPPA waiver practice; this card does not pin a specific waiver CFR quote.",
  "plain": "Most oral Rx drugs go in child-resistant caps. Know classic exemptions (e.g., SL nitroglycerin). Easy-open on patient/prescriber request is common practice \u2014 document it; check current CPSC guidance.",
  "confidence": 0.92,
  "citations": [
    {
      "authority": "16 CFR 1700.14",
      "url": "https://www.ecfr.gov/current/title-16/chapter-II/subchapter-E/part-1700/section-1700.14",
      "pin": "1700.14(a)(10)",
      "retrieved_at": "2026-09-08",
      "quote": "Prescription drugs. Any drug for human use that is in a dosage form intended for oral administration and that is required by Federal law to be dispensed only by or upon an oral or written prescription of a practitioner licensed by law to administer such drug shall be packaged in accordance with the provisions of \u00a7 1700.15 (a), (b), and (c), except for the following: (i) Sublingual dosage forms of nitroglycerin."
    }
  ],
  "updated_at": "2026-09-10",
  "token_cost_hint": 220,
  "integrity": "practice_only",
  "html": "/factors/ptce/federal/pppa-crc",
  "json": "/factors/ptce/federal/pppa-crc.json"
}